InvestorsHub Logo
Followers 43
Posts 899
Boards Moderated 0
Alias Born 05/12/2001

Re: None

Wednesday, 10/16/2019 9:43:32 AM

Wednesday, October 16, 2019 9:43:32 AM

Post# of 111
The Company is an emerging growth diagnostics company developing and marketing novel non-invasive gene expression tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. The Company’s technology provides a highly accurate alternative to surgical biopsy, eliminating patient pain, scarring, and risk of infection, while maximizing convenience. The Company’s scalable gene expression assays have been designed to work with a proprietary “adhesive patch biopsy” that provides a tissue sample for analysis non-invasively.

Reverse Merger 8K
https://www.sec.gov/Archives/edgar/data/1651944/000119312519238978/d790602d8k.htm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DMTK News